期刊文献+

前列腺特异抗原光激发化学发光免疫检测方法的建立 被引量:3

Development of light induced chemiluminescent immunoassay for prostate specific antigen
原文传递
导出
摘要 目的建立前列腺特异抗原(Prostate specific antigen,PSA)光激发化学发光免疫(Light induced chemilumines-cent immunoassay,LICA)定量检测方法。方法用PSA多克隆抗体包被受体微粒,PSA单克隆抗体标记生物素,两者与链霉亲和素包被的供体微粒共同组成检测试剂检测PSA,优化测定条件并对方法进行验证。分别采用本方法与Roche公司电化学发光免疫分析法对82份临床标本进行检测,并进行比较分析。结果本方法的分析灵敏度为0.31 ng/ml;批内变异系数为4.66%~6.75%,批间变异系数为5.68%~8.42%;回收率为95.1%~105.2%。两种方法具有较好的相关性,其R2为0.981 5。结论建立的均相化学发光免疫测定方法能够用于血清PSA的定量测定,且其性能指标符合临床要求。 Objective To develop a light induced chemiluminescent immunoassay(LICA) for quantitative determination of prostate specific antigen(PSA).Methods A LICA kit was developed,which consisted of the receptor particles coated with polyclonal antibody against PSA,the monoclonal antibody against PSA coated with biotin,and the donor particles coated with streptavidin.The condition for determination was optimized,and the developed method was verified.A total of 82 clinical samples were determined by the developed kit and electrochemiluminescent(ECL) immunoassay kit(Roche),and the results were compared.Results The analytical sensitivity of the developed method was 0.31 ng / ml.The intra-and inter-coefficients of variation of determination results were 4.66% ~ 6.75% and 5.68% ~ 8.42% respectively,while the recovery rate was 95.1% ~ 105.2%.The determination result by LICA showed high correlation with that by ECL immunoassay,of which the R2 value was 0.981 5.Conclusion The developed homogeneous chemiluminescent immunoassay method may be used for the quantitative detection of serum PSA,of which the performance meets the clinical requirements.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第1期117-119,共3页 Chinese Journal of Biologicals
基金 天津市滨海新区创新基金(2011-BR12001)
关键词 前列腺特异抗原 均相免疫分析 光激发化学发光免疫 Prostate specific antigen(PSA) Homogeneous immunoassay Light induced chemiluminescent immunoassay(LICA)
  • 相关文献

参考文献7

二级参考文献49

  • 1马宏伟,赵卫国,潘柏申.血清肌红蛋白光激化学发光免疫测定法的建立[J].检验医学,2006,21(1):55-57. 被引量:11
  • 2马宏伟,赵卫国,潘柏申.亲和层析法分离纯化人心肌肌钙蛋白Ⅰ[J].检验医学,2007,22(3):304-307. 被引量:3
  • 3Ullman EF, Kirakossian H, Singh S, et al. Luminescent oxygen channeling immunoassay : measurement of particle binding kinetics by chemiluminescence. Proc Natl Acad Sci U S A, 1994,91: 5426-5430.
  • 4Ullman EF, Kirakossian H, Switchenko AC, et al. Luminescent oxygen channeling assay ( LOCI ) : sensitive, broadly applicable homogeneous immunoassay method. Clin Chem, 1996,42 : 1518 1526.
  • 5Kricka LJ. Clinical applications of chemiluminescence. Anal Chim Acta, 2003,500:279-286.
  • 6Peppard J, Glickman F, He Y, et al. Development of a high- throughput screening assay for inhibitors of aggrecan cleavage using luminescent oxygen channeling (AlphaScreen). J Biomol
  • 7Soini JT, Waris ME, Hanninen PE. Detection methods of mierosphere based single-step bioaffinity and in vitro diagnostics assays. J Pharm Biomed Anal, 2004,34:753-760.
  • 8Gabriel D, Vernier M, Pfeifer MJ, et al. High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol, 2003,1:291-303.
  • 9Poulsen F, Jensen KB. A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma. J Biomol Screen, 2007,12:240-247.
  • 10Li Y, Choi M, Cavey G, et al. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell, 2005, 17:491-502.

共引文献28

同被引文献27

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部